Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

HEALTH MEDIA NOW-DR. JIM GARVIN CEO CYTOBIOSCIENCE-BETTER PATIENT OUTCOMES

  • Broadcast in Health
Health Media Now

Health Media Now

×  

Follow This Show

If you liked this show, you should follow Health Media Now.
h:544015
s:10997185
archived

Please join us Wednesday, September 26, 2018 at 4:00 p.m. PST and 7:00 p.m. EST for a live show with host Denise Messenger. Our guest is Dr. Jim Garvin, CEO of CytoBioscience.  We will be discussing how his company can help give patients better medical outcomes. 

James R. Garvin is the CEO, President and a Director of the CytoBioscience. Dr. Garvin has twenty-nine years of experience in working in the finance and biotech sectors. His work has been recognized by the French Academy of Science and he was named one of sixteen healthcare innovators in the state of Texas for 2017. As a former investment banker, he has worked on a number of different biotechnology acquisitions, in the US, Europe and Israel. He has been a board member of a different companies and currently is on the board of the Zerah Foundation which provides educational opportunities for underprivileged children in India. Additionally, he was one of the founding members of the International Christian Chamber of Commerce (ICCC), now in 87 countries around the world.  His international range of experiences and interests has been diverse but this has allowed him to have an outside of the box perspective that has served him well in working with companies and situations over the years. Dr. Garvin received his PhD in Urban Economic Systems from the University of New Orleans, as well as his Masters in Administration and his BA (Hons) in English and International Relations from the State University of New York, Albany.  You ask for it and we deliver.

 

 

Comments